Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02194439 · ClinicalTrials.gov registry record
Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 415
- Enrollment target
NCT02194439 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 415 participants.
The verdict
NCT02194439 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 415 participants
- Enrollment target
Study Summary
This study is designed to collect longitudinal biological samples from patients after hematopoietic cell transplantation (HCT) cared for at multiple bone marrow transplant centers to validate biomarkers of both acute and chronic GVHD as well as for use in future unspecified research. The centers include Dana-Farber Cancer Institute and Boston's Children's Hospital, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Fred Hutchinson Cancer Research Center, Texas Children's Hospital, Children's National Medical Center, and Indiana University Simon Cancer Center.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 415 participants |
| Start Date | 2014-01 |
| Est. Completion | 2019-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02194439
The ClinicalTrials.gov registry entry for NCT02194439 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 415 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02194439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02194439 about?
NCT02194439 is a clinical study titled "Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease". This study is designed to collect longitudinal biological samples from patients after hematopoietic cell transplantation (HCT) cared for at multiple bone marrow transplant centers to validate biomarkers of both acute and chronic GVHD as well as for use in future unspecified research. The centers inc...
What is the current status of trial NCT02194439?
This trial is currently completed. The enrollment target is 415 participants. The study started on 2014-01. Estimated completion is 2019-09-30.
Who is sponsoring clinical trial NCT02194439?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.